Cryptosporidium parvum infection rapidly induces a protective innate immune response involving type I interferon

Journal of Infectious Diseases

Volumn 200, Issue 10, 2009, Pages 1548-1555

  Barakat, Farah M ^a   McDonald, Vincent ^a   Foster, Graham R ^a   Tovey, Michael G ^b   Korbel, Daniel S ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b INSTITUT ANDRÉ LWOFF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERFERON; MESSENGER RNA; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; DENDRITIC CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTESTINE CELL; INTESTINE EPITHELIUM; MOUSE; NONHUMAN; OOCYST; PARASITE DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; ANIMAL; CELL STRAIN CACO 2; CRYPTOSPORIDIUM PARVUM; GENETICS; IMMUNOLOGY; PARASITOLOGY;

ANIMALS; CACO-2 CELLS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; ENTEROCYTES; HUMANS; IMMUNITY, INNATE; INTERFERON-ALPHA; INTERFERON-BETA; MICE; RNA, MESSENGER;

EID: 70449728436     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/644601     Document Type: Article

References (27)

1. Chen XM, Keithly JS, Paya CV, LaRusso NF. Current concepts: Cryptosporidiosis. New Engl J Med 2002; 346:1723-1731
2. Chen XM, O'Hara SP, Nelson JB, et al. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB. J Immunol 2005; 175:7447-7456
3. McDonald V, Smith R, Robinson H, Bancroft G. Host immune responses against Cryptosporidium. Contrib Microbiol 2000; 6:75-91.
4. Zaalouk TK, Bajaj-Elliott M, George JT, McDonald V. Differential regulation of beta-defensin gene expression during Cryptosporidium parvum infection. Infect Immun 2004; 72:2772-2779
5. Urban JF Jr, Fayer R, Chen SJ, Gause WC, Gately MK, Finkelman FD. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J Immunol 1996; 156: 263-268
6. McDonald V, Bancroft GJ. Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice. Parasite Immunol 1994; 16:315-320
7. Hayward AR, Chmura K, Cosyns M. Interferon-gamma is required for innate immunity to Cryptosporidium parvum in mice. J Infect Dis 2000; 182:1001-1004
8. Platanias LC. Mechanisms of type-I and type-II interferon-mediated signalling. Nat Rev Immunol 2005; 5:375-386
9. Koyama S, Ishii KJ, Coban C, Akira S. Innate immune response to viral infection. Cytokine 2008; 43:336-341
10. Bogdan C, Mattner J, Schleicher U. The role of type I interferons in non-viral infections. Immunol Rev 2004; 202:33-48. (Pubitemid 39576903) (Pubitemid 39576903)
11. McDonald SA, OGrady JE, Bajaj-Elliott M, et al. Protection against the early acute phase of Cryptosporidium parvum infection conferred by interleukin-4-induced expression of T helper 1 cytokines. J Infect Dis 2004; 190:1019-1025
12. Pollok RC, Farthing MJ, Bajaj-Elliott M, Sanderson IR, McDonald V. Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum. Gastroenterology 2001; 120:99-107. (Pubitemid 32061873)
13. Ngoi SM, Tovey MG, Vella AT. Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-alpha/beta. J Immunol 2008; 181:7670-7680
14. Choudhry N, Korbel DS, Zaalouk TK, Blanshard C, Bajaj-Elliott M, McDonald V. Interferon-γ-mediated activation of enterocytes in immunological control of Encephalitozoon intestinalis infection. Parasite Immunol 2009; 31:2-9.
15. Lean IS, McDonald SA, Bajaj-Elliott M, Pollok RC, Farthing MJ, McDonald V. Interleukin-4 and transforming growth factor beta have opposing regulatory effects on gamma interferon-mediated inhibition of Cryptosporidium parvum reproduction. Infect Immun 2003; 71: 4580-4585
16. Lean IS, Lacroix-Lamandé S, Laurent F, Mcdonald V. Role of tumor necrosis factor alpha in development of immunity against Cryptosporidium parvum infection. Infect Immun 2006; 74:4379-4382
17. Zhang SY, Jouanguy E, Sancho-Shimizu V, et al. Human toll-like receptor-dependent induction of interferons in protective immunity to viruses. Immunol Rev 2007; 220:225-236 (Pubitemid 350045567) (Pubitemid 350045567)
18. Barrier M, Lacroix-Lamande S, Mancassola R, et al. Oral and intraperitoneal administration of phosphorothioate oligodeoxynucleotides leads to control of Cryptosporidium parvum infection in neonatal mice. J Infect Dis 2006; 193:1400-1407
19. Rogers KA, Rogers AB, Leav BA, et al. MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice. Infect Immun 2006; 74:549-556
20. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002; 2:957-964 (Pubitemid 37323216) (Pubitemid 37323216)
21. Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003; 3:984-993
22. Marcial MA, Madara JL. Cryptosporidium: cellular localization, structural analysis of absorptive cell-parasite membrane-membrane interactions in guinea pigs, and suggestion of protozoan transport by M cells. Gastroenterology 1986; 90:583-594
23. +, and double-negative Peyer's patch dendritic cells. J Immunol 2001; 166: 4884-4890
24. Korbel DS, Finney OC, Riley EM. Natural killer cells and innate immunity to protozoan pathogens. Int J Parasitol 2004; 34:1517-1528
25. Biron CA, Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol 2001; 13:458-464 (Pubitemid 32728479) (Pubitemid 32728479)
26. Dann SM, Wang HC, Gambarin KJ, et al. Interleukin-15 activates human natural killer cells to clear the intestinal protozoan Cryptosporidium. J Infect Dis 2005; 192:1294-1302 (Pubitemid 41368432) (Pubitemid 41368432)
27. Johansson C, Wetzel JD, He J, Mikacenic C, Dermody TS, Kelsall BL. Type I interferons produced by hematopoietic cells protect mice against lethal infection by mammalian reovirus. J Exp Med 2007; 204:1349-1358 (Pubitemid 46919873) (Pubitemid 46919873)